These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 21593077)
1. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Freathy RM; Kazeem GR; Morris RW; Johnson PC; Paternoster L; Ebrahim S; Hattersley AT; Hill A; Hingorani AD; Holst C; Jefferis BJ; Kring SI; Mooser V; Padmanabhan S; Preisig M; Ring SM; Sattar N; Upton MN; Vollenweider P; Waeber G; Sørensen TI; Frayling TM; Watt G; Lawlor DA; Whincup PH; Tozzi F; Davey Smith G; Munafò M Int J Epidemiol; 2011 Dec; 40(6):1617-28. PubMed ID: 21593077 [TBL] [Abstract][Full Text] [Related]
2. Smoking status, snus use, and variation at the CHRNA5-CHRNA3-CHRNB4 locus in relation to obesity: the GLACIER study. Varga TV; Hallmans G; Hu FB; Renström F; Franks PW Am J Epidemiol; 2013 Jul; 178(1):31-7. PubMed ID: 23729684 [TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the 15q25 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) interacts with maternal self-reported smoking status during pregnancy to influence birth weight. Tyrrell J; Huikari V; Christie JT; Cavadino A; Bakker R; Brion MJ; Geller F; Paternoster L; Myhre R; Potter C; Johnson PC; Ebrahim S; Feenstra B; Hartikainen AL; Hattersley AT; Hofman A; Kaakinen M; Lowe LP; Magnus P; McConnachie A; Melbye M; Ng JW; Nohr EA; Power C; Ring SM; Sebert SP; Sengpiel V; Taal HR; Watt GC; Sattar N; Relton CL; Jacobsson B; Frayling TM; Sørensen TI; Murray JC; Lawlor DA; Pennell CE; Jaddoe VW; Hypponen E; Lowe WL; Jarvelin MR; Davey Smith G; Freathy RM; Hum Mol Genet; 2012 Dec; 21(24):5344-58. PubMed ID: 22956269 [TBL] [Abstract][Full Text] [Related]
4. Associations between variation in CHRNA5-CHRNA3-CHRNB4, body mass index and blood pressure in the Northern Finland Birth Cohort 1966. Kaakinen M; Ducci F; Sillanpää MJ; Läärä E; Järvelin MR PLoS One; 2012; 7(9):e46557. PubMed ID: 23029550 [TBL] [Abstract][Full Text] [Related]
5. Stratification by smoking status reveals an association of CHRNA5-A3-B4 genotype with body mass index in never smokers. Taylor AE; Morris RW; Fluharty ME; Bjorngaard JH; Åsvold BO; Gabrielsen ME; Campbell A; Marioni R; Kumari M; Hällfors J; Männistö S; Marques-Vidal P; Kaakinen M; Cavadino A; Postmus I; Husemoen LL; Skaaby T; Ahluwalia TS; Treur JL; Willemsen G; Dale C; Wannamethee SG; Lahti J; Palotie A; Räikkönen K; Kisialiou A; McConnachie A; Padmanabhan S; Wong A; Dalgård C; Paternoster L; Ben-Shlomo Y; Tyrrell J; Horwood J; Fergusson DM; Kennedy MA; Frayling T; Nohr EA; Christiansen L; Ohm Kyvik K; Kuh D; Watt G; Eriksson J; Whincup PH; Vink JM; Boomsma DI; Davey Smith G; Lawlor D; Linneberg A; Ford I; Jukema JW; Power C; Hyppönen E; Jarvelin MR; Preisig M; Borodulin K; Kaprio J; Kivimaki M; Smith BH; Hayward C; Romundstad PR; Sørensen TI; Munafò MR; Sattar N PLoS Genet; 2014 Dec; 10(12):e1004799. PubMed ID: 25474695 [TBL] [Abstract][Full Text] [Related]
6. A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Freathy RM; Ring SM; Shields B; Galobardes B; Knight B; Weedon MN; Smith GD; Frayling TM; Hattersley AT Hum Mol Genet; 2009 Aug; 18(15):2922-7. PubMed ID: 19429911 [TBL] [Abstract][Full Text] [Related]
7. Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers. Halldén S; Sjögren M; Hedblad B; Engström G; Hamrefors V; Manjer J; Melander O J Intern Med; 2016 Apr; 279(4):388-98. PubMed ID: 26689306 [TBL] [Abstract][Full Text] [Related]
8. High tobacco consumption lowers body weight: a Mendelian randomization study of the Copenhagen General Population Study. Winsløw UC; Rode L; Nordestgaard BG Int J Epidemiol; 2015 Apr; 44(2):540-50. PubMed ID: 25777141 [TBL] [Abstract][Full Text] [Related]
9. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. Wassenaar CA; Dong Q; Wei Q; Amos CI; Spitz MR; Tyndale RF J Natl Cancer Inst; 2011 Sep; 103(17):1342-6. PubMed ID: 21747048 [TBL] [Abstract][Full Text] [Related]
10. Nicotinic acetylcholine gene cluster CHRNA5-A3-B4 variants influence smoking status in a Bangladeshi population. Chaity NI; Sultana TN; Hasan MM; Shrabonee II; Nahid NA; Islam MS; Apu MNH Pharmacol Rep; 2021 Apr; 73(2):574-582. PubMed ID: 33675519 [TBL] [Abstract][Full Text] [Related]
11. Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males. Zhang Y; Jiang M; Li Q; Liang W; He Q; Chen W; He J PLoS One; 2016; 11(3):e0149946. PubMed ID: 26942719 [TBL] [Abstract][Full Text] [Related]
12. Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility. Zhang H; Kranzler HR; Poling J; Gelernter J Neuropsychopharmacology; 2010 Oct; 35(11):2211-24. PubMed ID: 20631687 [TBL] [Abstract][Full Text] [Related]
13. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population. Pérez-Morales R; González-Zamora A; González-Delgado MF; Calleros Rincón EY; Olivas Calderón EH; Martínez-Ramírez OC; Rubio J Ann Hum Genet; 2018 Nov; 82(6):415-424. PubMed ID: 29993116 [TBL] [Abstract][Full Text] [Related]
14. Variant within the promoter region of the CHRNA3 gene associated with FTN dependence is not related to self-reported willingness to quit smoking. Marques-Vidal P; Kutalik Z; Paccaud F; Bergmann S; Waeber G; Vollenweider P; Cornuz J Nicotine Tob Res; 2011 Sep; 13(9):833-9. PubMed ID: 21511889 [TBL] [Abstract][Full Text] [Related]
15. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. Chen LS; Hung RJ; Baker T; Horton A; Culverhouse R; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Lutz S; Rosenberger A; Aben KK; Andrew AS; Breslau N; Chang SC; Dieffenbach AK; Dienemann H; Frederiksen B; Han J; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden HF; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Heinrich J; Hokanson JE; Hunter DJ; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare D; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Kraft P; Amos CI; Bierut LJ J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25873736 [TBL] [Abstract][Full Text] [Related]
16. Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial. Culverhouse RC; Chen LS; Saccone NL; Ma Y; Piper ME; Baker TB; Bierut LJ Nicotine Tob Res; 2020 Feb; 22(2):248-255. PubMed ID: 30882151 [TBL] [Abstract][Full Text] [Related]
17. Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: gene and smoking status interaction. Greenbaum L; Rigbi A; Lipshtat N; Cilia R; Tesei S; Asselta R; Djaldetti R; Goldwurm S; Lerer B Parkinsonism Relat Disord; 2013 Jan; 19(1):72-6. PubMed ID: 22884254 [TBL] [Abstract][Full Text] [Related]
18. Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. Keskitalo K; Broms U; Heliövaara M; Ripatti S; Surakka I; Perola M; Pitkäniemi J; Peltonen L; Aromaa A; Kaprio J Hum Mol Genet; 2009 Oct; 18(20):4007-12. PubMed ID: 19628476 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide meta-analyses of smoking behaviors in African Americans. David SP; Hamidovic A; Chen GK; Bergen AW; Wessel J; Kasberger JL; Brown WM; Petruzella S; Thacker EL; Kim Y; Nalls MA; Tranah GJ; Sung YJ; Ambrosone CB; Arnett D; Bandera EV; Becker DM; Becker L; Berndt SI; Bernstein L; Blot WJ; Broeckel U; Buxbaum SG; Caporaso N; Casey G; Chanock SJ; Deming SL; Diver WR; Eaton CB; Evans DS; Evans MK; Fornage M; Franceschini N; Harris TB; Henderson BE; Hernandez DG; Hitsman B; Hu JJ; Hunt SC; Ingles SA; John EM; Kittles R; Kolb S; Kolonel LN; Le Marchand L; Liu Y; Lohman KK; McKnight B; Millikan RC; Murphy A; Neslund-Dudas C; Nyante S; Press M; Psaty BM; Rao DC; Redline S; Rodriguez-Gil JL; Rybicki BA; Signorello LB; Singleton AB; Smoller J; Snively B; Spring B; Stanford JL; Strom SS; Swan GE; Taylor KD; Thun MJ; Wilson AF; Witte JS; Yamamura Y; Yanek LR; Yu K; Zheng W; Ziegler RG; Zonderman AB; Jorgenson E; Haiman CA; Furberg H Transl Psychiatry; 2012 May; 2(5):e119. PubMed ID: 22832964 [TBL] [Abstract][Full Text] [Related]
20. Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease. Lococo F; Cesario A; Petracca-Ciavarella L; Granone P; Russo P Curr Med Chem; 2012; 19(34):5863-70. PubMed ID: 23061658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]